Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.72 USD | +2.65% | +0.51% | -21.05% |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
Feb. 23 | Sector Update: Health Care Stocks Mixed Premarket Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.05% | 1.63B | |
-9.60% | 12.14B | |
+73.43% | 3.94B | |
-33.60% | 2.19B | |
+30.99% | 1.14B | |
+9.17% | 852M | |
-12.33% | 545M | |
-41.02% | 419M | |
+28.48% | 249M | |
+4.73% | 234M |
- Stock
- Equities
- Stock Veracyte, Inc. - Nasdaq
- News Veracyte, Inc.
- Scotiabank Initiates Veracyte at Sector Outperform Rating With $33 Price Target